Draft:Cadence OTC
{{AFC submission|d|corp|u=63.232.133.254|ns=118|decliner=Ca|declinets=20241217140832|ts=20241118171221}}
{{AFC submission|d|corp|u=2603:7000:D1F0:75A0:E572:E1F4:90A2:B72A|ns=118|decliner=CFA|declinets=20241116224305|small=yes|ts=20241104160700}}
{{AFC submission|d|v|u=2603:7000:1EF0:A360:9F4:5F21:F056:EC16|ns=118|decliner=Utopes|declinets=20240823224208|reason2=adv|small=yes|ts=20240823024817}}
{{AFC comment|1=Borderline case; this article on [https://www.pharmamanufacturing.com/home/article/33001447/nevertheless-they-persisted Pharama Manufacturing] gives a lot of useful information, but I am not familiar with this publication. Searching the publication name on Google doesn't reveal much. The author at least says she is experienced in the manufacturing space.
[https://www.cspdailynews.com/general-merchandisehbc/lil-drug-store-becomes-exclusive-convenience-channel-distributor Same goes for CSP], but it should be fine for basic facts.
Overall, most sources are not independent of the subject and are quite short, giving little info. Ca talk to me! 14:08, 17 December 2024 (UTC)}}
{{AFC comment|1=Please remove the Medium citations; anyone can publish an article there, making it unreliable. Ca talk to me! 13:49, 17 December 2024 (UTC)}}
----
{{Short description|Consumer healthcare company offering affordable contraceptives without medical prescriptions.}}
{{Draft topics|medicine-and-health}}
{{AfC topic|org}}
{{Undisclosed paid|date=November 2024}}
{{Infobox company
| type =
| name = Cadence OTC
| foundation = {{start date and age|2016}}
U.S.
| founder = Dr. Malcolm Potts, Dr. Nap Hosang, and Samantha Miller
| location_city = Oakland, California
| location_country = U.S.
| area_served = United States
| industry = Consumer healthcare company
| products = Emergency contraceptive pills, Pregnancy tests, Birth control pills
| homepage = {{url|https://cadenceotc.com}}
| footnotes =
| key_people = Dr. Malcolm Potts (Founder)
Dr. Nap Hosang (Founder)
Samantha Miller (Founder)
}}
=Overview=
Cadence Health, Inc., also known as Cadence OTC, is a privately held consumer healthcare company in the United States.{{cite web | url=https://www.pharmamanufacturing.com/home/article/33001447/nevertheless-they-persisted| title=Nevertheless, they persisted| date=9 March 2023}}{{cite web | url=https://pitchbook.com/profiles/company/152403-85#overview| title=Cadence OTC Overview}} Founded by Dr. Malcolm Potts, Dr. Nap Hosang, and Samantha Miller in 2016 as a public benefit company (PBC) based in Oakland, California, Cadence OTC provides access to contraceptives without a medical prescription. {{cite web | url=https://medium.com/@aliciakim_74942/nap-hosang-public-health-entrepreneur-continues-fight-for-womens-health-7205a6eec09d| title=Nap Hosang: Public Health Entrepreneur Continues Fight for Women's Health| date=10 July 2017}}{{cite web | url=https://www.wmar2news.com/middaymaryland/cadence-otc-womens-health-resources| title=Cadence OTC - Women's Health Resources| date=24 July 2024}} Cadence OTC bought rights to two estrogen-progestin combined oral contraceptives, Lo/Ovral and Alesse, from Pfizer in 2016. {{cite web | url=https://www.cspdailynews.com/general-merchandisehbc/lil-drug-store-becomes-exclusive-convenience-channel-distributor| title=Lil' Drug Store Becomes Exclusive Convenience Channel Distributor for Emergency Contraceptive}}
Morning After Pill
Cadence OTC’s emergency contraceptive, the Morning After Pill, was launched in January 2024 and is available at convenience stores in the United States.{{cite web | url=https://kingscrowd.com/cadence-otc-on-wefunder-2024/| title=Cadence OTC| date=11 March 2024}}{{cite web | url=https://cstoredecisions.com/2024/09/11/over-the-counter-contraceptive-pill/| title=Over-the-Counter Contraceptive Pill| date=11 September 2024}} This OTC emergency contraceptive is designed to prevent pregnancy after unprotected sex or condom failure. Each Morning After Pill contains 1.5 mg Levonorgestrel.
Zena
Zena is Cadence OTC’s combination birth control pill that contains a dose of progestin and estrogen.{{cite web | url=https://www.ft.com/content/19599dda-7f4d-41d3-8b27-5eb16aadb458| title=US considers first over-the-counter birth control pill}}{{cite web | url=https://www.sfexaminer.com/news/business/oakland-company-cadence-otc-on-verge-of-birth-control-pill/article_d7ae92cc-2d8e-11ee-8880-1b563bbb4b7e.html| title=Bay Area company could be next with over-the-counter birth control| date=28 July 2023}} Cadence OTC has collaborated with the U.S. Food and Drug Administration (FDA) to enable the sale of its birth control pill, Zena, for over-the-counter sale through a process known as the “first–in-class Rx-to-OTC switch.” {{cite web | url=https://www.fiercepharma.com/pharma/perrigos-hra-pharma-jockeys-over-counter-nod-birth-control-pill| title=After Roe ruling, Perrigo's HRA Pharma asks FDA to make its birth control pill available OTC}}{{cite web | url=https://www.fox13memphis.com/news/trending/fda-to-consider-making-prescription-contraceptive-pill-available-over-the-counter/article_10c71eca-0289-52bf-a940-2145d2625c6c.html| title=FDA to consider making prescription contraceptive pill available over-the-counter| date=11 July 2022}}{{cite web | url=https://www.glamour.com/story/over-the-counter-birth-control-pill| title=Soon Birth Control Could Be Available Over the Counter | date=12 July 2022 }} As of July 2024, FDA approval for Zena is pending and is labeled as an investigational drug. {{cite web | url=https://www.usnews.com/news/health-news/articles/2022-07-11/fda-mulling-over-the-counter-sale-of-contraceptive-pill| title=FDA Mulling Over-the-Counter Sale of Contraceptive Pill}}
Partnerships
Funding
Cadence OTC received over $30 million USD in funding from investors, including Soros Economic Development Fund, RH Capital and NJF Capital, the Global Fund for Women, the Disney family, the Gamble family of Pathfinder International, Templeton World Charities, Tara Health, Educational Foundation of America, and celebrities like Elizabeth Banks, Damon Lindelof, and Heidi Lindelof.{{cite web | url=https://www.njfcapital.com/njf-capital-blog/2019/11/25/buckhill-capital-invests-in-cadence-healths-series-b-round| title=Buckhill Capital Invests in Cadence Health's Series B Round| date=25 November 2019}}
Leadership
- Samantha Miller: Co-Founder and CEO (2016-present)
- Malcolm Potts: Co-Founder and Scientific Advisor (2016-present)
- Dr. Nap Hosang: Co-Founder and Chief Medical Officer (2016-present)
- Dr. Simon Gilburt: Senior VP, Clinical Research & Medical Affairs (2020-present){{cite web | url=https://www.chpa.org/sites/default/files/media/docs/2023-09/Attendee%20List%20PDF_0918.pdf| title=2023 CHPA REGU:ATORY SCIENTIFIC & QUALITY CONFERENCE}}
- Michelle Chun: VP Operations (2023-present){{cite web | url=https://www.datanyze.com/companies/cadence-otc/1310055132| title=Cadence OTC}}
- Abigail Disney: Board Member
References
{{reflist}}